Bacuahon, Jan Robin Y.
HRN: 27-13-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/19/2025
06/01/2025
IV
600mg
Q6
Multiple Fracture Sec To RCI
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes